The number of additional high molecular risk mutations predicts outcome after hematopoietic stem cell transplantation in primary and secondary myelofibrosis. [PDF]
Finazzi MC +14 more
europepmc +1 more source
Defining remission following hematopoietic cell transplant for myelofibrosis: an international expert panel consensus. [PDF]
Salit RB +11 more
europepmc +1 more source
Which myelofibrosis patients benefit from treatment with ruxolitinib? A single-center experience. [PDF]
Belohlavkova P, Zak P, Radocha J.
europepmc +1 more source
A Rare Case of Myelofibrosis Progressing to BCR-ABL1-Positive Chronic Myeloid Leukemia With Discordant Molecular Testing. [PDF]
Badyal H, Dogra V, Dogra R, Shelke A.
europepmc +1 more source
Impact of Donor Type on Outcomes After Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT. [PDF]
Hernández-Boluda JC +24 more
europepmc +1 more source
A case report focusing on diagnosis and intervention of chronic myeloid leukemia in blast crisis (acute megakaryoblastic leukemia subtype). [PDF]
Liu L +8 more
europepmc +1 more source
Efficacy of Momelotinib in Myelofibrosis Patients: Results From a Multicenter Study. [PDF]
Martorelli MC +34 more
europepmc +1 more source
A rare der(Y)t(Y;1)(q12;q12) in a patient with post-polycythemic myelofibrosis: a case report.
Masahiro Manabe +11 more
openalex +1 more source

